Varvara Solodovnikova

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

Susan E. Dorman, Samuel G. Schumacher, David Alland et al. · The Lancet Infectious Diseases · 2017 · 691 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +17

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · New England Journal of Medicine · 2022 · 352 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Borisov Se, Keertan Dheda, Martin Enwerem et al. · European Respiratory Journal · 2017 · 302 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Multidrug-Resistant Tuberculosis in Europe, 2010–2011

Gunar Günther, Frank van Leth, Sofia Alexandru et al. · Emerging infectious diseases · 2015 · 102 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · The Lancet Respiratory Medicine · 2023 · 96 citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +12